Treatment Nuances in Cardiac Sarcoidosis

[...]we initiate steroid-sparing agents in most cardiac sarcoidosis patients given the prolonged anticipated therapy duration. [...]the authors define immunosuppression therapy candidates as those with documented inflammation and either advanced block, left ventricular dysfunction, or significant ve...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-01, Vol.69 (3), p.362-363
Main Authors: Sperry, Brett W., MD, Culver, Daniel, DO, Hachamovitch, Rory, MD, MSc
Format: Article
Language:English
Subjects:
Cardiology
Cardiomyopathies
Cardiovascular
Humans
Inflammation
Internal Medicine
Sarcoidosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]we initiate steroid-sparing agents in most cardiac sarcoidosis patients given the prolonged anticipated therapy duration. [...]the authors define immunosuppression therapy candidates as those with documented inflammation and either advanced block, left ventricular dysfunction, or significant ventricular dysrhythmia.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.08.084